Your browser doesn't support javascript.
loading
IMPACT trial: angiographic and intravascular ultrasound observations of the first human experience with mycophenolic acid-eluting polymer stent system
Abizaid, Alexandre; Albertal, Mariano; Ormiston, John; Londero, Hugo; Ruygrok, Peter; Seixas, Ana Cristina; Mattos, Luiz A; Staico, Rodolfo; Silva, Roberto L; Webster, Mark; Stewart, Jim; Paoletti, Francisco; Kataoka, Tori; Fitzgerald, Peter; Sousa, Amanda; Sousa, J Eduardo.
Affiliation
  • Abizaid, Alexandre; Instituto Dante Pazzanese de Cardiologia. BR
  • Albertal, Mariano; Instituto Dante Pazzanese de Cardiologia. BR
  • Ormiston, John; Mercy and Green Lane Hospitals. NZ
  • Londero, Hugo; Sanatorio Allende. AR
  • Ruygrok, Peter; Green Lane Hospital. NZ
  • Seixas, Ana Cristina; Instituto Dante Pazzanese de Cardiologia. BR
  • Mattos, Luiz A; Instituto Dante Pazzanese de Cardiologia. BR
  • Staico, Rodolfo; Instituto Dante Pazzanese de Cardiologia. BR
  • Silva, Roberto L; Instituto Dante Pazzanese de Cardiologia. BR
  • Webster, Mark; Green Lane Hospital. NZ
  • Stewart, Jim; Green Lane Hospital. NZ
  • Paoletti, Francisco; Sanatorio Allende. AR
  • Kataoka, Tori; Stanford University Medical Center. US
  • Fitzgerald, Peter; Stanford University Medical Center. US
  • Sousa, Amanda; Instituto Dante Pazzanese de Cardiologia. BR
  • Sousa, J Eduardo; Instituto Dante Pazzanese de Cardiologia. BR
Catheter Cardiovasc Interv ; 66: 491-495, 10 de novembro de 2005.
Article in English | Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1061834
Responsible library: BR79.1
Localization: BR79.1
RESUMO
The purpose of the study was to examine the safety and efficacy of two different formulations of mycophenolic acid (MPA)-eluting Duraflex stents on coronary de novo lesions. Recent data indicate that local delivery of MPA in the porcine overstretch coronary
ABSTRACT
model significantly reduces neointimal hyperplasia (NIH). Patients were divided into three consecutive groups. The first (n 5 50) and second (n 5 55) groups received moderate- and slow-release MPA-eluting Duraflex stent, respectively. The last group (n 5 50) received the bare metal Duraflex stent. Clinical, angiographic, and intravascular
Subject(s)
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Brazil Database: Sec. Est. Saúde SP / SESSP-IDPCPROD Main subject: Stents / Drug-Eluting Stents / Mycophenolic Acid Language: English Journal: Catheter Cardiovasc Interv Year: 2005 Document type: Article Institution/Affiliation country: Green Lane Hospital/NZ / Instituto Dante Pazzanese de Cardiologia/BR / Mercy and Green Lane Hospitals/NZ / Sanatorio Allende/AR / Stanford University Medical Center/US
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Brazil Database: Sec. Est. Saúde SP / SESSP-IDPCPROD Main subject: Stents / Drug-Eluting Stents / Mycophenolic Acid Language: English Journal: Catheter Cardiovasc Interv Year: 2005 Document type: Article Institution/Affiliation country: Green Lane Hospital/NZ / Instituto Dante Pazzanese de Cardiologia/BR / Mercy and Green Lane Hospitals/NZ / Sanatorio Allende/AR / Stanford University Medical Center/US